The NF-κB signaling pathway is a validated oncological target. Here, we applied scaffold hopping to IMD-0354, a presumed IKKβ inhibitor, and identified 4-hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide (4) as a nM-inhibitor of the NF-κB pathway. However, both 4 and IMD-0354, being potent inhibitors of the canonical NF-κB pathway, were found to be inactive in human IKKβ enzyme assays.
4-Hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide: a novel inhibitor of the canonical NF-κB cascade
PIPPIONE, Agnese Chiara
First
;FEDERICO, ANTONELLA;DUCIME, ALEX;SAINAS, STEFANO;BOSCHI, Donatella;BARGE, Alessandro;LUPINO, Elisa;PICCININI, Marco;AL KARADAGHI, SALAM;LOLLI, Marco Lucio
Last
2017-01-01
Abstract
The NF-κB signaling pathway is a validated oncological target. Here, we applied scaffold hopping to IMD-0354, a presumed IKKβ inhibitor, and identified 4-hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-1,2,5-thiadiazole-3-carboxamide (4) as a nM-inhibitor of the NF-κB pathway. However, both 4 and IMD-0354, being potent inhibitors of the canonical NF-κB pathway, were found to be inactive in human IKKβ enzyme assays.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Pippione et al ChemMedChem manuscript rebuttal vs finaleper IRIS.pdf
Open Access dal 02/09/2018
Descrizione: Articolo principale
Tipo di file:
POSTPRINT (VERSIONE FINALE DELL’AUTORE)
Dimensione
1.12 MB
Formato
Adobe PDF
|
1.12 MB | Adobe PDF | Visualizza/Apri |
|
articolo.pdf
Accesso riservato
Descrizione: Articolo principale
Tipo di file:
PDF EDITORIALE
Dimensione
1.49 MB
Formato
Adobe PDF
|
1.49 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
|
supplementary.pdf
Accesso aperto
Descrizione: dati sperimentali supplementari
Tipo di file:
MATERIALE NON BIBLIOGRAFICO
Dimensione
2.85 MB
Formato
Adobe PDF
|
2.85 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
